In our previous study, human fibroblast growth factor 1 was successfully fused with oleosomes, energy-storing organelles of seeds, which are considered to be excellent “expression carriers” for substances with a convenient purification process. The present work aimed to explore the beneficial effects of oleosomes fused with human fibroblast growth factor 1 (OLAF) on wound healing. The data showed marked improvements in terms of the angiogenesis, vascular integrity, collagen and inflammation on the wound sites of rats with a full-thickness skin defect. Moreover, the positive role of OLAF in promoting angiogenesis and its possible pathways were clarified in vivo and in vitro. The results showed that the number, length and branches of the blood vessels of the chick embryo chorioallantoic membrane were markedly increased after OLAF treatment. Meanwhile, the in vitro results also revealed that 100 ng/mL OLAF exhibited a promoting effect on the proliferation, migration and tube formation of human umbilical vein endothelial cells. In addition, the potential of OLAF to improve wound angiogenesis was demonstrated to be associated with an up-regulated PI3K/Akt pathway by transcriptome sequencing analysis and the introduction of a PI3K/Akt pathway inhibitor (LY294002). These findings suggest that OLAF has many prospects in the development of drugs for wound healing.

Genome-wide association studies (GWASs) of a large cohort of subjects with chronic obstructive pulmonary disease (COPD) have successfully identified multiple risk genes, including fibroblast growth factor 7 (FGF7). However, the underlying molecular mechanism influencing function of FGF7 and risk of COPD remains further study. In this study, we replicated the genetic association of variants near the FGF7 gene in 258 Chinese Han patients with COPD and 311 healthy controls. Additionally, we functionally evaluated a candidate causal variant upstream of the FGF7 gene. The most significant association was observed at rs12905203 (P = 5.9 × 10^− 3, odd ratio, OR = 1.516) that explains associations of previously reported variants at the FGF7 locus. Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation-quantitative polymerase chain reaction (ChIP-qPCR) assays showed that the risk allele of the variant was bound to activator protein 1 transcription factors (c-Fos and c-Jun) with a significantly reduced affinity and associated with decreased mRNA expression of FGF7 in fibroblast cells at both resting and PMA/Ionomycin-stimulated conditions. Overexpression of c-Fos and c-Jun proteins or stimulation with PMA/Ionomycin significantly increases mRNA expression of FGF7 in fibroblast cells. Bioinformatic analysis showed that the variant overlaps with multiple genetic regulatory marks, suggesting the regulatory DNA element might function as an enhancer for the FGF7 gene. Luciferase enhancer activity assays demonstrated that the DNA sequences carrying the variant produce enhancer activity while the risk allele of the variant reduces its activity. In this study, we demonstrated a consistent association of the FGF7 gene with COPD and mechanistically characterized a candidate functional variant upstream of the FGF7 gene. These data highlighted the important role of the risk variant and the FGF7 gene in influencing risk for COPD.

Oil body (OB), a subcellular organelle that stores oil in plant seeds, is considered a new transdermal drug delivery system. With the increasing understanding of the OB and its main protein (oleosi...

The purpose of this study was to express human FGF21 (hFGF21) using Cordyceps militaris (C. militaris) as a bioreactor and to observe its hypoglycemic and lipid-lowering effects on type II diabetes. The recombinant plasmid pCB130-hFGF21 was transformed into C. militaris to form recombinant recombinant C. militaris (RhFGF21), the stability of RhFGF21 in vitro and in vivo was analyzed. RhFGF21 significantly promoted glucose uptake in a dose-dependent manner in adipocytes and increased the levels of p-PLCγ, p-FRS2 and p-ERK, which was consistent with the commercial hFGF21. In animal experiments, oral RhFGF21 obviously reduced the levels of glucose, insulin, TG, T-CHO, NEFA, and LDL-C in the blood, the contents of ALT, AST, TNF-α, MCP-1, F4/80, CD68 and CD11b in the fatty liver, and the apoptosis of pancreatic cells. C. militaris is an excellent carrier that can stabilize the expression of hFGF21 and protect the biological activity of hFGF21 during oral administration, which provides a theoretical basis for the development of hFGF21 oral preparations for type II diabetes.

Sulfometuron-methyl (SM), as a sulfonylurea herbicide, is widely used in agricultural production. In recent years, it has also been employed in the control and management of Spartina alterniflora in some coastal areas of China. Its potential risks to aquatic ecosystems have drawn increasing attention. However, the current data on the systematic toxicity assessment of SM in model organisms is still very limited. This study used zebrafish (Danio rerio) as an in vivo model to systematically evaluate the toxic effects of SM on early embryonic development and focused on the mediating mechanism of the Wnt/β-catenin signaling pathway in it. Zebrafish embryos were exposed to different concentrations (10, 20, 40 mg/L) of SM starting from 1.75 hpf until 72 hpf. The results showed that SM significantly increased the embryo mortality rate, decreased the hatching rate, and induced developmental malformations such as shortened body length and yolk sac edema in a concentration-dependent manner. At the mechanism level, SM exposure significantly reduced the number of H3P-positive mitotic active cells in the embryos, suggesting that fewer cells entered mitosis; meanwhile, the activities of superoxide dismutase (SOD) and catalase (CAT) showed compensatory changes, indicating that oxidative stress was induced in the embryos, which may contribute to subsequent cellular damage. qRT-PCR analysis further revealed that SM exposure downregulated the transcriptional levels of cell cycle-related genes (CyclinD1, CDK4, CDK6), while upregulating the expression of apoptosis-related genes (p53, bax, caspase-9, caspase-3), suggesting that cell cycle arrest and the dysregulation of the endogenous apoptotic pathway were activated. Additionally, SM exposure could dysregulate the Wnt/β-catenin signaling pathway, specifically manifested as significant upregulation of target genes C-myc and Ctnnb2, and significant downregulation of the negative regulatory factor Axin2. Using the Wnt/β-catenin pathway-specific inhibitor IWR-1 for intervention could partially reverse the embryonic developmental retardation phenotypes induced by SM, providing additional evidence for the mediating role of this pathway in the developmental toxicity of SM. In summary, this study systematically elucidates the multi-level molecular mechanism by which SM induces oxidative stress and cell apoptosis through the abnormal dysregulation of the Wnt/β-catenin signaling pathway, reduced mitotic activity, and ultimately drives the toxicity of zebrafish embryo development. This provides new experimental evidence and a theoretical basis for the aquatic ecological risk assessment of SM.